We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlue Star Regulatory News (BLU)

Share Price Information for Blue Star (BLU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0325
Bid: 0.03
Ask: 0.035
Change: 0.00 (0.00%)
Spread: 0.005 (16.667%)
Open: 0.0325
High: 0.0325
Low: 0.0325
Prev. Close: 0.0325
BLU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants and Director’s Dealing

9 Nov 2020 07:00

RNS Number : 5934E
Blue Star Capital plc
09 November 2020
 

9 November 2020

 

Blue Star Capital plc

 

("Blue Star" or the "Company")

 

Exercise of Warrants and Director's Dealing

 

 

Blue Star Capital plc (AIM: BLU), the investing company with a focus on esports, payments, technology and its applications within media and gaming, has been notified of the exercise of warrants over 95,000,000 new ordinary shares at a price of 0.1p per share and of a director's dealing as detailed below.

 

Exercise of Warrants

 

On 14 October 2019, the Company announced that had agreed to issue warrants to Jonathan Bixby, through his Company Toro Consulting Ltd and to certain directors conditional on the completion of the initial fundraising in connection with the Company's esports investment portfolio. The warrants granted included warrants over 300,000,000 new ordinary shares with an exercise date of 6 November 2020 and an exercise price of 0.1p per share.

 

The Company was notified on 6 November 2020 that shareholders including Anthony Fabrizi, a director of the Company, had exercised warrants over 95,000,000 new ordinary shares ("New Ordinary Shares"). The exercise of the warrants has raised £95,000 for the Company and the remainder of the warrants due to mature on 6 November 2020 have now expired.

 

Following the exercise and expiry of warrants detailed above, the Company has warrants outstanding over 1,299,333 new ordinary shares of which 707,666 warrants are exercisable at 0.175p on or before 8 June 2021 and 591,667 warrants are exercisable at 0.25p on or before 6 November 2021.

 

In connection with his exercise of warrants, Anthony Fabrizi notified the Company on 6 November 2020 that, on the same day, he sold 10,000,000 shares in the Company at an average price of 0.152p.

 

Director's Dealing

 

As a result of the exercise of warrants and the sale of shares detailed above, the following dealings by a director have occurred:

 

Name

Holding prior to transactions

Number of shares sold

Number of shares acquired subject to exercise of warrants

Holding following sale and Admission

Holding as a percentage of issued share capital following Admission

 

 

 

 

 

 

Anthony Fabrizi

 

62,000,000

10,000,000

25,000,000

77,000,000

1.86%

 

 

Application will shortly be made for the 95,000,000 New Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on or around 13 November 2020. The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares.

 

Total Voting Rights

 

In conformity with DTR 5.6.1, the Company notifies that as at the date of this announcement, it has a single class of shares in issue being Ordinary Shares and that following the issue of the New Ordinary Shares to be issued in connection with the conversion of his loan notes, the total number of Ordinary Shares in issue will be 4,144,249,518. There are no Ordinary Shares held in treasury. Each Ordinary Share entitles the holder to a single vote at general meetings of the Company.

 

The figure of 4,144,249,518 Ordinary Shares may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The following disclosure in the table below, in accordance with the requirements of Article 19(1) of Regulation (EU) No. 596/2014, provides further detail on the sale of shares and exercise of warrants.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

For further information please contact:

 

Blue Star Capital plc

Tony Fabrizi

 

 

+44 (0) 777 178 2434

 

Cairn Financial Advisers LLP

Jo Turner / Liam Murray

 

 

 +44 (0) 20 7213 0880

 

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a.

Name

Anthony Fabrizi

 

2

Reason for notification

 

a.

Position/Status

Chief Executive Officer

 

b.

Initial notification/

Amendment

Initial

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a.

Name

Blue Star Capital PLC

 

b.

LEI

213800WAVVOPS85N2205

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares

 

 

ISIN: GB00B02SSZ25

 

 

 

b.

Nature of the transaction

Sale of shares at a price of 0.152 pence

Exercise of warrants at an exercise price of 0.1 pence

 

c.

Price(s) and volume(s)

 

 

 

 

 

 

Volume(s)

Exercise Price (p)

 

 

10,000,000

0.152

 

 

 

25,000,000

0.1

 

 

 

 

d.

Aggregated information

- Aggregated Volume

- Price

35,000,000

 

0.152 and 0.1 pence per share

 

e.

Date of the transaction

06/11/2020

 

 

f.

Place of the transaction

London Stock Exchange, AIM

 

 

         

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKCBQKBDKKDK
Date   Source Headline
18th Apr 20247:00 amRNSResult of AGM
15th Apr 202412:00 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSFurther re Pendulum: Spacewalk launch on Pendulum
21st Mar 20247:01 amRNSFinal Results
13th Mar 20247:00 amRNSDynasty Gaming and Media Merger
16th Feb 20243:00 pmRNSHolding(s) in Company
19th Jan 20244:25 pmRNSFurther re: Fundraise
17th Jan 20247:00 amRNSFundraise, Issue of Warrants & Broker Appointment
16th Jan 20247:00 amRNSPortfolio Update
27th Nov 20237:00 amRNSDynasty Update
15th Nov 20237:00 amRNSSatoshiPay Update
9th Oct 20239:08 amRNSDirectorate Change
28th Jun 20237:00 amRNSHalf-year Report
1st Jun 20239:32 amRNSPendulum: Spacewalk bridge released on Amplitude
2nd May 20237:00 amRNSDynasty Launches Partnership with Lets Play Live
3rd Apr 20237:00 amRNSResult of AGM
14th Mar 20237:00 amRNSPendulum Announces Blockchain Bridge
7th Mar 20237:00 amRNSFinal Results
14th Feb 20234:56 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSPendulum Mainnet Launch
30th Jan 20237:00 amRNSGrant of Warrants
30th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPendulum Completes Crowdloan
25th Nov 20224:53 pmRNSTR-1: Standard notification of major holdings
25th Nov 20222:47 pmRNSHolding(s) in Company
31st Oct 20227:49 amRNSDynasty Investment Update
5th Oct 20224:18 pmRNSHolding(s) in Company
28th Sep 20227:00 amRNSTrading Update and Investment Portfolio Review
27th Sep 20227:15 amRNSGuild Reduces David Beckham Payment Obligations
26th Sep 20227:12 amRNSGuild Signs Sponsorship Deal with Sky UK
23rd Sep 202210:19 amRNSHolding(s) in Company
21st Sep 20227:00 amRNSHolding(s) in Company
16th Sep 20227:36 amRNSDirectorate Changes
16th Sep 20227:00 amRNSDirectorate Changes
8th Sep 20227:00 amRNSHolding(s) in Company
15th Aug 202212:05 pmRNSTR-1: Standard notification of major holdings
30th Jun 20227:00 amRNSHalf-year Report
19th Apr 20221:37 pmRNSResult of AGM
11th Apr 20221:09 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSDynasty Gaming & Media new partnership agreements
25th Mar 20221:00 pmRNSFinal Results
9th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSHolding(s) in Company
20th Jan 202211:05 amRNSSecond Price Monitoring Extn
20th Jan 202211:00 amRNSPrice Monitoring Extension
18th Jan 20227:14 amRNSGuild Sponsorship Deal
17th Jan 20227:00 amRNSSatoshiPay Directorate Changes and Update
6th Jan 202212:07 pmRNSHolding(s) in Company
5th Jan 20227:00 amRNSStatement re Share Price Movement
8th Dec 20213:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.